Atahar imam Hasan: Universal Artificial Blood and the Future of Trauma Care
Atahar imam Hasan, Internship Trainee at Yacca Group, shared a post on LinkedIn:
“Japanese scientists at Nara Medical University are developing a universal artificial blood that could transform transfusion medicine.
Produced by extracting hemoglobin from expired donor blood and encapsulating it in lipid-based particles that mimic red blood cells, it can safely transport oxygen without requiring blood type matching.
Unlike donated blood, which requires refrigeration and expires in about 42 days, this artificial blood can be stored for up to two years at room temperature (or five years when refrigerated).
Its long shelf life, universal compatibility, and lower risk of transfusion-transmitted infections make it especially valuable for trauma care, disaster response, military medicine, and regions with limited blood supplies.
Human trials that began in 2022 have shown the artificial blood to be safe in healthy volunteers, with no serious side effects. Larger-dose studies (100–400 mL) are now underway to further assess its safety and effectiveness.
If successful, it could be introduced into hospitals by around 2030, marking one of the most significant advances in transfusion medicine in decades.
Source: Laws, J. (2025). Artificial Blood That Could Work for All Blood Types in Trials. Newsweek.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke